findmyKOL
Clinical trialNCT04384523CompletedPhase 1Interventional

A Study of OsrHSA in Adult Healthy Male and Female Volunteers

SponsorHealthgen Biotechnology Corp.Enrollment41Ascites Hepatic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 1 randomized, double blinded, placebo-controlled single dose escalation study of OsrHSA in adult healthy male and female volunteers
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Wcct Global, Inc

    Cypress, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

OsrHSA 140 mg/kg IVOsrHSA 20 mg/kg IVOsrHSA 200 mg/kg IVOsrHSA 40 mg/kg IVOsrHSA 80 mg/kg IV
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Nov 2019
Primary completion
17 Mar 2020
Completion
13 Jul 2020
Last update posted
1 Jun 2021
Registered enrollment
41
Registry id
NCT04384523
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.